These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 20534994)
21. Intraductal spread of pancreatic cancer. Clinicopathologic study of 54 pancreatectomized patients. Yamasaki S; Suda K; Nobukawa B; Sonoue H Pancreatology; 2002; 2(4):407-12. PubMed ID: 12138230 [TBL] [Abstract][Full Text] [Related]
22. Long-term survival after surgical resection for pancreatic cancer. Yoshizawa K; Nagai H; Kurihara K; Sata N; Kawai T; Saito K Hepatogastroenterology; 2001; 48(40):1153-6. PubMed ID: 11490822 [TBL] [Abstract][Full Text] [Related]
23. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects. Adsay NV; Basturk O; Cheng JD; Andea AA Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479 [TBL] [Abstract][Full Text] [Related]
24. Acinar cell carcinoma of the pancreas metastatic to the ovary: a report of 4 cases. Vakiani E; Young RH; Carcangiu ML; Klimstra DS Am J Surg Pathol; 2008 Oct; 32(10):1540-5. PubMed ID: 18724247 [TBL] [Abstract][Full Text] [Related]
25. Sequential progression and intraductal spread of invasive ductal adenocarcinoma of the pancreas arising from around the main pancreatic duct. Tajiri T; Tate G; Ohike N; Kunimura T; Mitsuya T; Morohoshi T Hepatogastroenterology; 2005; 52(63):745-8. PubMed ID: 15966196 [TBL] [Abstract][Full Text] [Related]
27. [Acinar cell carcinoma of the pancreas with predominant intraductal growth: report of a case]. Svrcek M; Lesurtel M; Lewin M; Afchain P; Fabre M; Scoazec JY; Parc R; Fléjou JF Gastroenterol Clin Biol; 2007 May; 31(5):543-6. PubMed ID: 17541347 [TBL] [Abstract][Full Text] [Related]
28. A clinicopathologic and immunohistochemical study of 35 anaplastic carcinomas of the pancreas with a review of the literature. Paal E; Thompson LD; Frommelt RA; Przygodzki RM; Heffess CS Ann Diagn Pathol; 2001 Jun; 5(3):129-40. PubMed ID: 11436166 [TBL] [Abstract][Full Text] [Related]
29. Acinar cell carcinoma of the pancreas: is the absence of neuroendocrine component related to a more malignant behavior? Machado MC; Machado MA; Perini MV; Herman P; Jukemura J; Leite KR; Bacchella T Hepatogastroenterology; 2008; 55(82-83):708-10. PubMed ID: 18613439 [TBL] [Abstract][Full Text] [Related]
30. Intraductal papillary or mucinous tumors (IPMT) of the pancreas: report of a case series and review of the literature. Zamora C; Sahel J; Cantu DG; Heyries L; Bernard JP; Bastid C; Payan MJ; Sielezneff I; Familiari L; Sastre B; Barthet M Am J Gastroenterol; 2001 May; 96(5):1441-7. PubMed ID: 11374680 [TBL] [Abstract][Full Text] [Related]
31. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer. Helm J; Centeno BA; Coppola D; Melis M; Lloyd M; Park JY; Chen DT; Malafa MP Cancer; 2009 Sep; 115(18):4080-9. PubMed ID: 19626671 [TBL] [Abstract][Full Text] [Related]
32. The mode of lymphatic and local spread of pancreatic carcinomas less than 4.0 cm in size. Ohta T; Nagakawa T; Ueno K; Kayahara M; Mori K; Kobayashi H; Takeda T; Miyazaki I Int Surg; 1993; 78(3):208-12. PubMed ID: 8276542 [TBL] [Abstract][Full Text] [Related]
33. Lymphatic vessel density and vascular endothelial growth factor-C expression correlate with malignant behavior in human pancreatic endocrine tumors. Rubbia-Brandt L; Terris B; Giostra E; Dousset B; Morel P; Pepper MS Clin Cancer Res; 2004 Oct; 10(20):6919-28. PubMed ID: 15501970 [TBL] [Abstract][Full Text] [Related]
34. Pancreatic acinar cell carcinoma with extensive tumor embolism at the trunk of portal vein and pancreatic intraductal infiltration. Kida A; Matsuda K; Takegoshi K; Matsuda M; Sakai A; Noda Y Clin J Gastroenterol; 2017 Dec; 10(6):546-550. PubMed ID: 28921102 [TBL] [Abstract][Full Text] [Related]
35. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma. Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881 [TBL] [Abstract][Full Text] [Related]
36. Pancreatic carcinoma: < or = 2 cm versus > 2 cm in size. Yamaguchi K; Mizumoto K; Noshiro H; Sugitani A; Shimizu S; Chijiiwa K; Tanaka M Int Surg; 1999; 84(3):213-9. PubMed ID: 10533779 [TBL] [Abstract][Full Text] [Related]
37. Ets-2 overexpression contributes to progression of pancreatic adenocarcinoma. Ito Y; Miyoshi E; Takeda T; Sakon M; Ihara S; Tsujimoto M; Matsuura N Oncol Rep; 2002; 9(4):853-7. PubMed ID: 12066221 [TBL] [Abstract][Full Text] [Related]
38. Solid and pseudopapillary tumor of the pancreas--review and new insights into pathogenesis. Geers C; Moulin P; Gigot JF; Weynand B; Deprez P; Rahier J; Sempoux C Am J Surg Pathol; 2006 Oct; 30(10):1243-9. PubMed ID: 17001154 [TBL] [Abstract][Full Text] [Related]
39. Pancreatic endocrine tumour with ductules: further observations of an unusual histological subtype. Chetty R; Serra S; Asa SL; Volkan Adsay N Pathology; 2006 Feb; 38(1):5-9. PubMed ID: 16484000 [TBL] [Abstract][Full Text] [Related]
40. Where and when does pancreatic carcinoma start? Lüttges J; Hahn S; Klöppel G Med Klin (Munich); 2004 Apr; 99(4):191-5. PubMed ID: 15085289 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]